DOI QR코드

DOI QR Code

Comparison of QSAR Methods (CoMFA, CoMSIA, HQSAR) of Anticancer 1-N-Substituted Imidazoquinoline-4,9-dione Derivatives


Abstract

Comparison studies of the Quantitative Structure Activity Relationship (QSAR) methods with new imidazo-quinolinedione derivatives were conducted using Comparative Molecular Field Analysis (CoMFA), Comparative Molecular Similarity Indices Analysis (CoMSIA), and the Hologram Quantitative Structure Activity Relationship (HQSAR). When the CoMFA crossvalidation value, q2, was 0.625, the Pearson correlation coefficient, r2, was 0.973. In CoMSIA, q2 was 0.52 and r2 was 0.979. In the HQSAR, q2 was 0.501 and r2 was 0.924. The best result was obtained using the CoMSIA method according to a comparison of the calculated values with the real in vitro cytotoxic activities against human ovarian cancer cell lines.

Keywords

References

  1. Rao, K. V.; Cullen, W. P. Antibiot. Ann. 1968, 950, 1959.
  2. Johnson, F.; Shaikh, I. A.; Grollmann, A. P. J. Med. Chem. 1986,29, 1329. https://doi.org/10.1021/jm00158a002
  3. Inouye, Y.; Take, Y.; Oogose, K. J. Antibiotics 1987, 40, 105. https://doi.org/10.7164/antibiotics.40.105
  4. Rao, K. V. Cancer Chemother. Rep. 1974, part 2, 4, 11.
  5. Hackethal, C. A.; Golbey, P. B.; Tan, C. T. C.; Karnofsky, D. A.;Burchenal, J. H. Antibiotic Cheother. 1961, 11, 178.
  6. Humphrey, E. W.; Blank, N.; Medrek, T. J. Cancer Chemother.Rep. 1961, 12, 99.
  7. Rivers, S. L.; Wittington, R. M.; Spencer, H. H.; Pento, M. E.Cancer 1966, 19, 1377. https://doi.org/10.1002/1097-0142(196610)19:10<1377::AID-CNCR2820191008>3.0.CO;2-L
  8. Kremer, W. B.; Laszlo, J. Cancer Chemotheraphy Rep. 1967, 51,19.
  9. Foye, W. O. Cancer Chemotherapeutic Agents; American ChemicalSociety press: Washington, U.S.A., 1995; 645.
  10. Lown, J. W.; Joshus, A. V.; Lee, J. S. Biochemistry 1982, 21, 419. https://doi.org/10.1021/bi00532a001
  11. Yamashita, Y.; Tsubata, Y.; Suzuki, T.; Miyashi, T.; Mukai, T.;Tanaka, Y. Chem. Lett. 1990, 1990, 445.
  12. Kuo, S. C.; Ibuka, T.; Huang, L. J.; Lednica, D. J. Med. Chem.1996, 39, 1447. https://doi.org/10.1021/jm950247k
  13. Suh, M. E.; Kang, M. J.; Yoo, H. W.; Park, S. Y.; Lee, C. O.Bioorg. & Med. Chem. 2000, 8, 2079. https://doi.org/10.1016/S0968-0896(00)00132-2
  14. Moore, M. H.; Hunter, W. H.; Kennard, O. J. Mol. Biol. 1987,206, 693. https://doi.org/10.1016/0022-2836(89)90577-9
  15. HQSAR., Version 1.0; Tripos. Inc.: St. Louis, MO, 1999.
  16. Winkler, D. A.; Burden, T. R. Quant. Struct. Act. Relat. 1998, 17,224. https://doi.org/10.1002/(SICI)1521-3838(199806)17:03<224::AID-QSAR224>3.3.CO;2-Y
  17. Cramer, R. D., III; Patterson, D. E.; Bunce, J. D. J. Am. Chem.Soc. 1988, 110, 5959. https://doi.org/10.1021/ja00226a005
  18. Klebe, G.; Abraham, U.; Mietzner, T. J. Med. Chem. 1994, 37, 24,4130. https://doi.org/10.1021/jm00050a010
  19. So, S. S.; Karplus, M. J. Med. Chem. 1997, 40, 4360. https://doi.org/10.1021/jm970488n
  20. Malinowski, E. R.; Howery, D. G. Factor Analysis in Chemistry;Wiley: New York, 1980.

Cited by

  1. Bound Ligand Conformer Revealed by Flexible Structure Alignment in Absence of Crystal Structures: Indirect Drug Design Probed for HIV-1 Protease Inhibitors vol.5, pp.3, 2009, https://doi.org/10.1021/ct8004886
  2. 3D-QSAR Study for Checkpoint Kinase 2 Inhibitors through Pharmacophore Hypotheses pp.20100221, 2013, https://doi.org/10.7763/IJCEA.2013.V4.263
  3. MTD-comsia modelling of HMG-CoA reductase inhibitors vol.76, pp.1, 2011, https://doi.org/10.2298/JSC100601019D
  4. 2D and 3D QSAR studies of diarylpyrimidine HIV-1 reverse transcriptase inhibitors vol.22, pp.11, 2008, https://doi.org/10.1007/s10822-008-9217-4
  5. Ligand-based QSAR Studies on the Indolinones Derivatives as Inhibitors of the Protein Tyrosine Kinase of Fibroblast Growth Factor Receptor by CoMFA and CoMSIA vol.25, pp.12, 2002, https://doi.org/10.5012/bkcs.2004.25.12.1801
  6. Synthesis of novel aminoquinonoid analogues of diospyrin and evaluation of their inhibitory activity against murine and human cancer cells vol.43, pp.9, 2002, https://doi.org/10.1016/j.ejmech.2007.11.028
  7. Simple Screening Method for Double-strand DNA Binders Using Hairpin DNA-modified Magnetic Beads vol.32, pp.1, 2002, https://doi.org/10.5012/bkcs.2011.32.1.247
  8. Novel Design Strategy for Checkpoint Kinase 2 Inhibitors Using Pharmacophore Modeling, Combinatorial Fusion, and Virtual Screening vol.2014, pp.None, 2002, https://doi.org/10.1155/2014/359494
  9. Three Dimensional Quantitative Structure Activity Relationship and Pharmacophore Modeling of Tacrine Derivatives as Acetylcholinesterase Inhibitors in Alzheimer's Treatment vol.16, pp.2, 2020, https://doi.org/10.2174/1573406415666190513100646